Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Ann Hematol ; 96(7): 1085-1095, 2017 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-28421266

RESUMO

The adverse effects of iron overload have raised more concerns as a growing number of studies reported its association with immune disorders. This study aimed to investigate alterations in the immune system by iron overload in patients with myelodysplastic syndrome (MDS) and an iron-overloaded mouse model. The peripheral blood from patients was harvested to test the effect of iron overload on the subsets of T lymphocytes, and the level of reactive oxygen species (ROS) was also evaluated. The data showed that iron-overloaded patients had a lower percentage of CD3+ T cells and disrupted T cell subsets, concomitant with higher ROS level in lymphocytes. In order to explore the mechanism, male C57Bl/6 mice were intraperitoneally injected with iron dextran at a dose of 250 mg/kg every 3 days for 4 weeks to establish an iron-overloaded mouse model and the blood of each mouse was collected for the analysis of the T lymphocyte subsets and T cell apoptosis. The results showed that iron overload could reduce the percentage of CD3+ T cells and the ratio of Th1/Th2 and Tc1/Tc2 but increase the percentage of regulatory T (Treg) cells and the ratio of CD4/CD8. We also found that iron overload induced the apoptosis of T lymphocytes and increased its ROS level. Furthermore, these effects could be partially recovered after treating with antioxidant N-acetyl-L-cysteine (NAC) or iron chelator deferasirox (DFX). Taken together, these observations indicated that iron overload could selectively affect peripheral T lymphocytes and induce an impaired cellular immunity by increasing ROS level.


Assuntos
Sobrecarga de Ferro/metabolismo , Síndromes Mielodisplásicas/metabolismo , Espécies Reativas de Oxigênio/metabolismo , Subpopulações de Linfócitos T/metabolismo , Idoso , Idoso de 80 Anos ou mais , Animais , Complexo CD3/sangue , Relação CD4-CD8 , Modelos Animais de Doenças , Feminino , Citometria de Fluxo , Humanos , Sobrecarga de Ferro/sangue , Contagem de Linfócitos , Masculino , Camundongos Endogâmicos C57BL , Pessoa de Meia-Idade , Síndromes Mielodisplásicas/sangue , Linfócitos T/metabolismo , Linfócitos T Reguladores/metabolismo , Células Th1/metabolismo , Células Th2/metabolismo
2.
Neurochem Res ; 42(2): 360-374, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27743286

RESUMO

Temporal lobe epilepsy (TLE) is one of the most refractory types of adult epilepsy, and treatment options remain unsatisfactory. Gastrodin (GAS), a phenolic glucoside used in Chinese herbal medicine and derived from Gastrodia elata Blume, has been shown to have remarkable anticonvulsant effects on various models of epilepsy in vivo. However, the mechanisms of GAS as an anticonvulsant drug remain to be established. By utilizing a combination of behavioral surveys, immunofluorescence and electrophysiological recordings, the present study characterized the anticonvulsant effect of GAS in a pilocarpine-induced status epilepticus (SE) rat model of TLE and explored the underlying cellular mechanisms. We found that GAS pretreatment effectively reduced the severity of SE in the acute phase of TLE. Moreover, GAS protected medial entorhinal cortex (mEC) layer III neurons from neuronal death and terminated the SE-induced bursting discharge of mEC layer II neurons from SE-experienced rats. Furthermore, the current study revealed that GAS prevented the pilocarpine-induced enhancement of Nav1.6 currents (persistent (INaP) and resurgent (INaR) currents), which were reported to play a critical role in the generation of bursting spikes. Consistent with this result, GAS treatment reversed the expression of Nav1.6 protein in SE-experienced EC neurons. These results suggest that the inhibition of Nav1.6 sodium currents may be the underlying mechanism of GAS's anticonvulsant properties.


Assuntos
Álcoois Benzílicos/uso terapêutico , Epilepsia do Lobo Temporal/tratamento farmacológico , Glucosídeos/uso terapêutico , Canal de Sódio Disparado por Voltagem NAV1.6/fisiologia , Pilocarpina/toxicidade , Bloqueadores dos Canais de Sódio/uso terapêutico , Estado Epiléptico/tratamento farmacológico , Animais , Álcoois Benzílicos/farmacologia , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Epilepsia do Lobo Temporal/fisiopatologia , Glucosídeos/farmacologia , Masculino , Ratos , Ratos Sprague-Dawley , Índice de Gravidade de Doença , Bloqueadores dos Canais de Sódio/farmacologia , Estado Epiléptico/induzido quimicamente , Estado Epiléptico/fisiopatologia
3.
Platelets ; 23(8): 638-44, 2012.
Artigo em Inglês | MEDLINE | ID: mdl-22111667

RESUMO

To explore the role of CD72 in the pathogenesis of immune thrombocytopenia (ITP), we detected CD72, Sema4D, IL-2, IL-4, and IFN-γ mRNA expressions and the levels of plasma Sema4D, IL-2, IL-4, IL-6, and IFN-γ in ITP patients (n = 39) and controls (n = 23). The levels of plasma IL-2, IL-4, and IL-6 were assayed by radioimmunoassay, and the levels of plasma IFN-γ and Sema4D were analyzed by enzyme-linked immunosorbent assay. Sema4D, CD72, IL-2, IFN-γ, and IL-4mRNA expressions were analyzed by real-time quantitative reverse-transcription polymerase chain reaction. The expression of CD72 mRNA in ITP patients (n = 23) with active disease was significantly lower than that in patients in remission (p = 0.029) (n = 16) and controls (p = 0.0296) (n = 23). The IFN-γ/IL-4 mRNA (Th1/Th2) expression in ITP patients with active disease and in remission was significantly higher than that in controls (p = 0.0023, p = 0.0125, respectively). The expression of IL-2 mRNA in ITP patients with active disease was significantly lower than that in patients in remission (p = 0.0418) and controls (p = 0.004). The level of plasma IL-2 in ITP patients with active disease was significantly lower than that in patients in remission (p = 0.0029) and controls (p = 0.0101). The levels of plasma IL-4 in ITP patients with active disease and in remission were significantly higher than that of controls (p = 0.0093, p = 0.0053, respectively). CD72 mRNA expression level might correlate with Sema4D mRNA expression in peripheral blood mononuclear cells and level of plasma IL-2 in active ITP patients (p = 0.024 and p = 0.036). Our findings suggest that CD72 might be involved in the pathophysiological process of the ITP disease by increasing B-cell receptor signals.


Assuntos
Antígenos CD/genética , Antígenos de Diferenciação de Linfócitos B/genética , Expressão Gênica , Interleucina-2/genética , Púrpura Trombocitopênica/genética , RNA Mensageiro/genética , Semaforinas/genética , Doença Aguda , Adulto , Idoso , Antígenos CD/sangue , Antígenos de Diferenciação de Linfócitos B/sangue , Estudos de Casos e Controles , Convalescença , Feminino , Humanos , Interferon gama/sangue , Interferon gama/genética , Interleucina-2/sangue , Interleucina-4/sangue , Interleucina-4/genética , Interleucina-6/sangue , Interleucina-6/genética , Masculino , Pessoa de Meia-Idade , Púrpura Trombocitopênica/sangue , Semaforinas/sangue
4.
Neuroscience ; 337: 355-369, 2016 Nov 19.
Artigo em Inglês | MEDLINE | ID: mdl-27670903

RESUMO

Rhynchophylline (RIN) is a significant active component isolated from the Chinese herbal medicine Uncaria rhynchophylla. Several studies have demonstrated that RIN has a significant anticonvulsant effect in many types of epilepsy models in vivo. However, the mechanisms of the anticonvulsant effect remain elusive. Using combined methods of behavioral testing, immunofluorescence and electrophysiological recordings, we characterized the anticonvulsant effect of RIN in a pilocarpine-induced status epilepticus (SE) rat model of temporal lobe epilepsy (TLE) and investigated the underlying cellular mechanisms. In one set of experiments, rats received RIN treatment prior to pilocarpine injection. In a second set of experiments, rats received RIN treatment following the onset of stage 3 seizures. Pretreatment and posttreatment with RIN effectively reduced the seizure severity in the acute phase of TLE. Furthermore, RIN protected medial entorhinal cortex (mEC) layer III neurons from neuronal death and terminated spontaneous epileptiform discharge of mEC layer II neurons in SE-experienced rats. Whole-cell voltage-clamp recordings indicated that RIN inhibited neuronal hyperexcitability via inhibition of the persistent sodium current (INaP) and NMDA receptor current. Immunofluorescence experiments also demonstrated that RIN rectified the pilocarpine-induced upregulation of Nav1.6 and NR2B protein expression. In conclusion, our results identified RIN as an anticonvulsant agent that inhibited ictal discharge via INap and NMDA receptor current inhibition.


Assuntos
Anticonvulsivantes/farmacologia , Epilepsia do Lobo Temporal/tratamento farmacológico , Alcaloides Indólicos/farmacologia , Receptores de N-Metil-D-Aspartato/efeitos dos fármacos , Sódio/metabolismo , Animais , Modelos Animais de Doenças , Córtex Entorrinal/efeitos dos fármacos , Epilepsia do Lobo Temporal/metabolismo , Hipocampo/efeitos dos fármacos , Hipocampo/metabolismo , Neurônios/metabolismo , Oxindóis , Pilocarpina/farmacologia , Ratos Sprague-Dawley , Receptores de N-Metil-D-Aspartato/metabolismo , Estado Epiléptico/induzido quimicamente
5.
Hum Immunol ; 73(3): 240-7, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22210084

RESUMO

Primary immune thrombocytopenia (ITP) is an acquired, organ-specific, autoimmune disease with many immune dysfunctions. Interleukin-27 (IL-27) can regulate T cell differentiation. However, it is unclear whether IL-27 correlates with the dysfunctions of T cell differentiation in ITP patients. Thus, to determine the roles of IL-27 in ITP, we studied the expression of IL-27/IL-27 receptor in ITP patients. The results indicated that the levels of IL-27 in the plasma of untreated active ITP patients were higher than in normal controls. We next evaluated the contribution of IL-27 to T cell differentiation. Our results indicated that IL-27 increased T-bet expression, inhibited GATA-3 and ROR-γt expression, and promoted the secretion of tumor necrosis factor-α, interferon-γ, and granzyme B of peripheral blood mononuclear cells from ITP patients. Also, we confirmed that IL-27 induced the differentiation of T helper (Th)-1 and Tc1 cells. In conclusion, IL-27 might play an important role in the pathogenesis of ITP by inducing the polarization of Th1/Tc1 cells and the production of proinflammatory cytokines.


Assuntos
Interleucinas/metabolismo , Púrpura Trombocitopênica Idiopática/imunologia , Linfócitos T/metabolismo , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Células Cultivadas , Citocinas/genética , Citocinas/metabolismo , Feminino , Regulação da Expressão Gênica/imunologia , Humanos , Mediadores da Inflamação/metabolismo , Interleucinas/genética , Interleucinas/imunologia , Masculino , Pessoa de Meia-Idade , Receptores de Interleucina/genética , Receptores de Interleucina/metabolismo , Linfócitos T/imunologia , Linfócitos T/patologia , Equilíbrio Th1-Th2 , Fatores de Transcrição/genética , Fatores de Transcrição/metabolismo , Adulto Jovem
6.
Brain Res ; 1401: 52-8, 2011 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-21663896

RESUMO

Short-term sleep deprivation (SD) has been shown to enhance cortical activity. However, alterations in the cellular excitability of cortical neurons following SD are not yet fully understood. The present study investigated the effects of 4-hour SD on pyramidal neurons in the prefrontal cortex (PFC) of rats using whole-cell patch-clamp recording. SD led to an increase in the initial slope of firing frequency-current curve and a decrease in frequency adaptation, which were reversed by recovery sleep (RS). Correspondingly, the total afterhyperpolarization (AHP) was reduced in the SD group and returned in the RS group. Furthermore, the component of AHP changed after SD seemed to be sensitive to Ca(2+). These observations indicate an enhancement in intrinsic excitability due to short-term SD, and suggest a role for Ca(2+)-dependent AHP in this change. The findings of the present study may provide a possible explanation for the SD-induced increase in cortical activity.


Assuntos
Potenciais de Ação/fisiologia , Neurônios/fisiologia , Córtex Pré-Frontal/patologia , Privação do Sono/patologia , Privação do Sono/fisiopatologia , Animais , Córtex Pré-Frontal/fisiologia , Células Piramidais/patologia , Células Piramidais/fisiologia , Ratos , Ratos Sprague-Dawley , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa